← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LYNE · Approved 2018-05-21

Drug application

FDA Application #

ANDA209082

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

LYNE

Manufacturer

Leading Pharma, LLC

First approval

2018-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown